Inclusive of all taxes
Cefepime Hydrochloride for Injection 250 mg is a potent fourth-generation cephalosporin antibiotic meticulously formulated as a sterile dry powder for injection. Designed specifically for intravenous (IV) or intramuscular (IM) administration, this antibiotic targets a broad spectrum of bacterial pathogens by effectively inhibiting bacterial cell wall synthesis, ultimately causing bacterial cell death. Its advanced generation status ensures enhanced resistance against beta-lactamases and increased efficacy against both Gram-positive and Gram-negative bacteria, including multi-drug resistant strains. This makes Cefepime Hydrochloride a critical therapeutic option in hospital and clinical settings for managing severe infections such as pneumonia, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and febrile neutropenia.
Key Features
| Features | Description |
|---|---|
| Form | Sterile dry powder for injection |
| Strength | 250 mg per vial |
| Route of Administration | Intravenous (IV) or Intramuscular (IM) injection |
| Antibiotic Generation | Fourth-generation cephalosporin |
| Mechanism of Action | Inhibits bacterial cell wall synthesis causing bacterial cell death |
| Spectrum of Activity | Broad spectrum against Gram-positive and Gram-negative bacteria including resistant strains |
| Indications | Treatment of severe bacterial infections including pneumonia, UTI, skin & soft tissue infections, intra-abdominal infections, febrile neutropenia |
| Packaging | Sterile single-dose vial |
| Stability | Stable when reconstituted as per manufacturer guidelines for use in clinical settings |
| Attributes | Description |
|---|---|
| Active Ingredient | Cefepime Hydrochloride |
| Dosage Strength | 250 mg |
| Physical Form | Lyophilized powder for injection |
| Storage Conditions | Store in a cool, dry place below 25°C; protected from light |
| Shelf Life | Typically 24 months from manufacturing date |
| Reconstitution | Reconstitute with appropriate diluent (e.g. sterile water for injection) before administration |
| Manufacturer Compliance | Produced under GMP standards complying with Indian regulatory requirements |
| Sterility | Sterile and pyrogen-free |
| Packaging Type | Glass vial with rubber stopper and aluminum seal |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
It is recommended for intravenous (IV) or intramuscular (IM) injection as per clinical guidelines.
Yes, being a fourth-generation cephalosporin, Cefepime Hydrochloride is effective against many multi-drug resistant Gram-negative and Gram-positive bacteria.
The product should be stored in a cool, dry place below 25°C and protected from light to maintain stability and efficacy.
Yes, the product is sterile, pyrogen-free, and manufactured under GMP standards adhering to Indian regulatory requirements.
It is indicated for severe bacterial infections including pneumonia, urinary tract infections, skin and soft tissue infections, intra-abdominal infections, and febrile neutropenia.
Country Of Origin: India
Cefepime Hydrochloride for Injection 250 mg is a fourth-generation cephalosporin antibiotic used for treating a wide range of bacterial infections. Here's a summary:
Cefepime Hydrochloride for Injection 250 mg is a fourth-generation cephalosporin antibiotic used for treating a wide range of bacterial infections. Here's a summary:
Key Features:
Form: Dry powder for injection.
Strength: 250 mg.
Route of Administration: Intravenous (IV) or intramuscular (IM).
Mechanism of Action: Cefepime works by inhibiting bacterial cell wall synthesis, which leads to bacterial cell death.
Inclusive of all taxes
You Save: 0
